Showing results (141-150 of 264) with videos related to

Sort By:
Pageof 27
Circulation|April 10, 2023
Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart AssociationLaxmi S Mehta, Gladys P Velarde, Jennifer Lewey, et al.
Genes, Chromosomes & Cancer|July 16, 2009
Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysisKylie L Gorringe, Manasa Ramakrishna, Louise H Williams, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer familiesHeather Thorne, Amber J Willems, Eveline Niedermayr, et al.
Acta Pharmacologica Sinica|April 27, 2018
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examplesRui Xue Zhang, Jason Li, Tian Zhang, et al.
Combinatorial Chemistry & High Throughput Screening|October 27, 2020
Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational StudyWei Yu, Xiaomin Wu, Jiayi Ren, et al.
BJU International|May 3, 2014
Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohortDamien Bolton, Yuan Cheng, Amber J Willems-Jones, et al.
Urologic Oncology|November 21, 2015
Searching for candidate genes in familial BRCAX mutation carriers with prostate cancerSally M Hunter, Simone M Rowley, David Clouston, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 17, 2016
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumorRui Xue Zhang, Ping Cai, Tian Zhang, et al.
Journal of the National Cancer Institute|September 22, 2018
Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor ImmunityMohammad Ali Amini, Azhar Z Abbasi, Ping Cai, et al.
Nature Communications|January 22, 2024
Proteomic screens of SEL1L-HRD1 ER-associated degradation substrates reveal its role in glycosylphosphatidylinositol-anchored protein biogenesisXiaoqiong Wei, You Lu, Liangguang Leo Lin, et al.
Pageof 27